Blair William & Co. IL Has $16.75 Million Stock Position in Encompass Health Co. (NYSE:EHC)

Blair William & Co. IL lessened its position in shares of Encompass Health Co. (NYSE:EHCFree Report) by 10.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 249,453 shares of the company’s stock after selling 30,043 shares during the quarter. Blair William & Co. IL owned approximately 0.25% of Encompass Health worth $16,753,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of the company. UBS Group AG grew its holdings in shares of Encompass Health by 7.4% during the 3rd quarter. UBS Group AG now owns 174,458 shares of the company’s stock worth $11,717,000 after purchasing an additional 11,945 shares in the last quarter. State of New Jersey Common Pension Fund D boosted its stake in Encompass Health by 12.4% in the 3rd quarter. State of New Jersey Common Pension Fund D now owns 54,557 shares of the company’s stock valued at $3,664,000 after buying an additional 6,023 shares in the last quarter. HighTower Advisors LLC boosted its stake in Encompass Health by 27.6% in the 3rd quarter. HighTower Advisors LLC now owns 13,791 shares of the company’s stock valued at $930,000 after buying an additional 2,983 shares in the last quarter. Pathstone Family Office LLC acquired a new stake in Encompass Health in the 3rd quarter valued at $300,000. Finally, Vanguard Personalized Indexing Management LLC boosted its stake in Encompass Health by 8.5% in the 3rd quarter. Vanguard Personalized Indexing Management LLC now owns 6,734 shares of the company’s stock valued at $452,000 after buying an additional 526 shares in the last quarter. Institutional investors and hedge funds own 92.66% of the company’s stock.

Insider Activity at Encompass Health

In related news, CFO Douglas E. Coltharp sold 11,215 shares of the company’s stock in a transaction dated Monday, November 13th. The stock was sold at an average price of $63.39, for a total value of $710,918.85. Following the completion of the sale, the chief financial officer now owns 116,293 shares in the company, valued at $7,371,813.27. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.90% of the stock is currently owned by corporate insiders.

Encompass Health Trading Down 0.7 %

NYSE EHC opened at $72.93 on Friday. The stock has a 50-day simple moving average of $68.70 and a 200 day simple moving average of $67.50. The company has a market capitalization of $7.31 billion, a PE ratio of 21.02, a P/E/G ratio of 1.39 and a beta of 0.92. The company has a current ratio of 1.28, a quick ratio of 1.27 and a debt-to-equity ratio of 1.19. Encompass Health Co. has a 12 month low of $51.15 and a 12 month high of $76.84.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on EHC. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research note on Wednesday. Royal Bank of Canada reiterated an “outperform” rating and issued a $83.00 price objective on shares of Encompass Health in a research report on Friday. Stephens reiterated an “overweight” rating and issued a $85.00 price objective on shares of Encompass Health in a research report on Tuesday, January 16th. Mizuho lifted their price objective on Encompass Health from $77.00 to $82.00 and gave the company a “buy” rating in a research report on Friday. Finally, Truist Financial lifted their price objective on Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research report on Friday. One equities research analyst has rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $79.89.

View Our Latest Report on Encompass Health

Encompass Health Profile

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

See Also

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHCFree Report).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.